These results demonstrate that UTI has an anti-inflammatory therapeutic potential in the prevention of PPO and consequent AL, which may result from the inhibition of the expression of proinflammatory mediators via NF-κB and MAPKs partial inactivation. This evidence concerns the gene NFKB1 and bacterial urinary tract infection.